The global renal cancer drug market is projected to grow at a significant CAGR during the forecast period. The market is segmented on the basis of cancer type, drug class, and therapeutic class. Based on the cancer type, the market is segmented into renal cancer carcinoma, clear cell renal cell carcinoma, non-clear renal cell carcinoma, and others.